Literature DB >> 22147739

Role of nonclinical factors in the receipt of high-quality systemic adjuvant breast cancer treatment.

Jennifer J Griggs.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22147739     DOI： 10.1200/JCO.2011.39.4270

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

Authors:  Harold J Burstein; Sarah Temin; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford A Hudis; Diana Rowden; Alexander J Solky; Vered Stearns; Eric P Winer; Jennifer J Griggs
Journal:  J Clin Oncol       Date:  2014-05-27       Impact factor: 44.544

2.  Comparing the Hospital-Acquired Condition Reduction Program and the Accreditation of Cancer Program: A Cross-sectional Study.

Authors:  Aaron Spaulding; Rachel Paul; Dorin Colibaseanu
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

3.  Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform.

Authors:  Kirsten Y Eom; G J van Londen; Jie Li; Bassam Dahman; Cathy Bradley; Lindsay M Sabik
Journal:  BMC Cancer       Date:  2021-05-01       Impact factor: 4.430

4.  The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.

Authors:  Carol A Parise; Vincent Caggiano
Journal:  J Cancer Epidemiol       Date:  2015-08-03

5.  Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.

Authors:  Carol A Parise; Vincent Caggiano
Journal:  BMC Cancer       Date:  2013-10-02       Impact factor: 4.430

6.  Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis.

Authors:  Ruth P Norris; Rosie Dew; Linda Sharp; Alastair Greystoke; Stephen Rice; Kristina Johnell; Adam Todd
Journal:  BMC Med       Date:  2020-10-23       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.